Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.44 USD | -32.31% | -48.24% | -97.08% |
Apr. 15 | Acorda Therapeutics Delisted from Nasdaq, Now Trading on OTC Pink Market | MT |
2023 | Transcript : Acorda Therapeutics, Inc., Q2 2023 Earnings Call, Aug 08, 2023 |
Financials (USD)
Sales 2022 | 119M | Sales 2023 | 118M | Capitalization | 529K |
---|---|---|---|---|---|
Net income 2022 | -65M | Net income 2023 | -253M | EV / Sales 2022 | - |
Net Debt 2022 | 135M | Net Debt 2023 | 161M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.23
x | P/E ratio 2023 |
-0.07
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.33% |
Latest transcript on Acorda Therapeutics, Inc.
1 week | -48.24% | ||
Current month | -37.14% | ||
1 month | -49.98% | ||
3 months | -97.16% | ||
6 months | -95.57% | ||
Current year | -97.08% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.44 | -32.31% | 23,555 |
24-05-09 | 0.65 | -16.67% | 2,503 |
24-05-08 | 0.78 | -11.26% | 1,577 |
24-05-07 | 0.879 | +9.87% | 5,359 |
24-05-06 | 0.8 | -5.88% | 10,987 |
Delayed Quote Nasdaq, May 10, 2024 at 03:07 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- ACOR.Q Stock
- ACOR Stock